Cornea/External Disease News

The FDA approved expanded indication language to allow the use of teprotumumab for the treatment of thyroid eye disease for any level of activity or duration, according to a press release.

The risk for Acanthamoeba keratitis increases threefold with reusable contact lens wear compared with daily disposable lens wear, highlighting the importance of safe use guidelines, according to research in Ophthalmology.

Azithromycin showed equivalent efficacy to doxycycline in treating moderate to severe meibomian gland dysfunction, with reduced dosing and potentially fewer gastrointestinal adverse events, a study found.

VILAMOURA, Portugal — A high-resolution aberrometer prototype using astrophysics technology revealed unprecedented micro alterations in the wavefront phase of keratoconus eyes, which are dependent on the disease stage.

The incidence of microbial keratitis in children wearing soft contact lenses is no higher than that reported in adults, while the incidence of corneal infiltrative events is lower, according to a literature review in Eye & Contact Lens.

PHILADELPHIA — Symptom severity and socioeconomic factors may contribute to follow-up adherence in patients with infectious keratitis, according to a speaker.

VILAMOURA, Portugal — At the ESCRS winter meeting, Emilio Torres-Netto, MD, PhD, speaks about the advantages of PTK-assisted customized epi-on cross-linking, or PACE.

Brim Biotechnology submitted an investigational new drug application to the FDA for BRM424 for the treatment of neurotrophic keratitis, according to a press release.

VILAMOURA, Portugal — Topography-guided corneal cross-linking for progressive keratoconus leads to stable inferior corneal Kmax flattening and superior corneal steepening, with significant improvement of vision, according to a study.

Neurotrophic keratitis is a relatively rare disease that can be difficult to manage, and treatment varies depending on disease stage.